Reuters -- Orthovita Inc lost a third of its market value on Thursday, a day after a medical journal reported a common spine operation that would use one of Orthovita's new products was no more effective than make-believe surgery.
Reuters -- Orthovita Inc lost a third of its market value on Thursday, a day after a medical journal reported a common spine operation that would use one of Orthovita's new products was no more effective than make-believe surgery.
